Evidence map›Paper›PMID 25527564›Full record

Trial reportHaematologica2015

Episodic angioedema with eosinophilia (Gleich syndrome) is a multilineage cell cycling disorder.

Paneez Khoury, Jacqueline Herold, Alexandra Alpaugh, Ellen Dinerman, Nicole Holland-Thomas, Jennifer Stoddard, Shakuntala Gurprasad, Irina Maric, Olga Simakova, Lawrence B Schwartz and 6 more

2 registry-linked trialsOpen access · goldAbstract readClinical Trial
In one paragraph

Trial report in Haematologica, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00001406 recruitingnot on this map

Eosinophil Activation and Function in Parasitic Infections and Other Conditions With Increased Tissue or Peripheral Blood Eosinophilia in Humans

TypeobservationalSponsorNational Institute of Allergy and Infectious Diseases (NIAID)Ran1997Enrolled800ConditionsImmune System Diseases, Eosinophilia, Helminthiasis, Hypersensitivity
NCT04128371 phase2terminatednot on this mapstarted 2021, after this paper: background citation

Pilot Study of Mepolizumab in Episodic Angioedema With Eosinophilia

TypeinterventionalSponsorNational Institute of Allergy and Infectious Diseases (NIAID)Ran2021 to 2022Enrolled5ConditionsEosinophilia, AngioedemaArmsmepolizumab
3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 69 citations in OpenAlex.

  1. Eosinophils and eosinophil-associated diseases: An update.The Journal of allergy and clinical immunology · 2018
    Pooled it
  2. Review
  3. Article
  4. Expansion of multiple CD4The Journal of allergy and clinical immunology · 2025
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Nonepisodic angioedema with eosinophilia after COVID-19 vaccination: a case successfully treated with reslizumab.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2023
    Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Roles of Immune Cells in Hereditary Angioedema.Clinical reviews in allergy & immunology · 2021
    Review
  16. Review
  17. Eosinophils in skin diseases.Seminars in immunopathology · 2021
    Review
  18. Review
  19. Episodic angioedema with eosinophilia (Gleich's syndrome) associated with urticarial vasculitis: a coincidence or a novel clinical entity?Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2021
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Paneez KhouryLaboratory of Parasitic Diseases, NIAID, National Institutes of Health, Bethesda, MD khouryp@niaid.nih.gov.
Jacqueline HeroldLaboratory of Parasitic Diseases, NIAID, National Institutes of Health, Bethesda, MD.
Alexandra AlpaughLaboratory of Parasitic Diseases, NIAID, National Institutes of Health, Bethesda, MD.
Ellen DinermanLaboratory of Parasitic Diseases, NIAID, National Institutes of Health, Bethesda, MD.
Nicole Holland-ThomasLaboratory of Parasitic Diseases, Clinical Research Directorate/CMRP, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, MD.
Jennifer StoddardDepartment of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD.
Shakuntala GurprasadDepartment of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD.
Irina MaricDepartment of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD.
Olga SimakovaDepartment of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD.
Lawrence B SchwartzDepartment of Internal Medicine, Division of Rheumatology, Allergy and Immunology, Virginia Commonwealth University, Richmond, VA.
Juelia FongLaboratory of Parasitic Diseases, NIAID, National Institutes of Health, Bethesda, MD.
Chyi-Chia Richard LeeLaboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Liqiang XiLaboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Zengfeng WangLaboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Mark RaffeldLaboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Amy D KlionLaboratory of Parasitic Diseases, NIAID, National Institutes of Health, Bethesda, MD.
National Institutes of Health · USNational Institutes of Health Clinical Center · USLeidos (United States) · USVirginia Commonwealth University · US

Funding

Eosinophils and Eosinophil Activation in the Pathogenesis of Human DiseaseZIAAI001130 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI KLION, AMY · 2010 to 2025
$22.5M
Immunohistochemistry Core LaboratoryZICBC011087 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI RAFFELD, MARK · 2009 to 2015
$7.4M
Laboratory Assessment of Patients with Hypereosinophilic SyndromeZIACL080004 · CLC · CLINICAL CENTER · PI MARIC, IRINA · 2009 to 2025
$0k
Intramural NIH HHSPHS HHS HHSN2610080001E
6 · The paper itself

Abstract

Episodic angioedema with eosinophilia (Gleich syndrome) is a rare disorder characterized by episodes of angioedema and eosinophilia that occur at monthly intervals and resolve spontaneously without therapy. Despite the striking periodicity of this disorder, its similarity to other cyclic hematopoietic disorders with multilineage involvement has not been assessed. To characterize the involvement of cell lineages in the etiology and pathogenesis of episodic angioedema with eosinophilia, four subjects were evaluated by blood counts and other analyses over the course of 1-2 months. Surface marker expression was assessed on T cells by flow cytometry and clonality by polymerase chain reaction. Intracellular cytokine evaluation, bone marrow and skin biopsies were performed during different parts of the cycle. Cycling of multiple cell lineages, including neutrophils, lymphocytes and eosinophils, was observed in the four subjects with the disorder with a periodicity of 25-35 days. An aberrant CD3(-)CD4(+) T-cell population was detected in all four subjects, and T-cell receptor rearrangement studies showed a clonal pattern in three subjects. A peak of type II cytokines was detected in the serum of subjects prior to the onset of symptoms and eosinophil cycling and corresponded to ex-vivo type II cytokines detected intracellularly in CD3(+)CD4(+)CD154(+) T cells. Although the etiology of episodic angioedema with eosinophilia is not yet known, multiple lineages, including lymphocytes, neutrophils and mast cells, are involved and may be related to disease pathogenesis. Whether these cells act directly or promote eosinophilia and eosinophil activation remains to be elucidated. All subjects gave informed consent and were evaluated under an Institutional Review Board-approved protocol (NCT00001406).

Indexed as

AdultAngioedemaAntigens, CDBone MarrowCell LineageCytokinesEosinophiliaEosinophilsFemaleGene ExpressionHumansImmunophenotypingMaleMast CellsMiddle AgedNeutrophilsAntigens, CDCytokines

Identifiers

PMID25527564
PMCPMC4349267
OpenAlexW2114583539

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.